» Articles » PMID: 33488279

Mesenchymal Stem Cells for Restoring Endometrial Function: An Infertility Perspective

Overview
Journal Reprod Med Biol
Specialty Biology
Date 2021 Jan 25
PMID 33488279
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mesenchymal stem cells (MSCs) can be derived from several tissues such as bone marrow, placenta, adipose tissue, or endometrial tissue. MSCs gain a lot of attention for cell-based therapy due to their characteristics including differentiation ability and immunomodulatory effect. Preclinical and clinical studies demonstrated that MSCs can be applied to treat female infertility by improving of the functions of ovary and uterus. This mini- review focuses on the current study of treatment of endometrial infertility by using MSCs.

Methods: The present study performed a literature review focusing on the effect of MSCs for treatment of women infertility caused by endometrial dysfunction.

Results: Bone marrow-, umbilical cord-, adipose-, amniotic-, and menstruation-derived MSCs enhance endometrial cell proliferation, injury repairs as well as reducing scar formation. The beneficial mechanism probably via immunomodulatory, cell differentiation, stimulates endometrial cell proliferation and down-regulation of fibrosis genes. The major advantage of using MSCs is to improve endometrial functions resulting in increased implantation and pregnancy.

Conclusions: MSCs exhibit a potential for endometrial infertility treatment. Adipose- and menstruation-derived stem cells show advantages over other sources because the cells can be derived easily and do not causes graft rejection after autologous transplantation.

Citing Articles

A Comprehensive Review of Advanced Diagnostic Techniques for Endometriosis: New Approaches to Improving Women's Well-Being.

Kaspute G, Bareikiene E, Prentice U, Uzieliene I, Ramasauskaite D, Ivaskiene T Medicina (Kaunas). 2024; 60(11).

PMID: 39597051 PMC: 11596456. DOI: 10.3390/medicina60111866.


Application of Mesenchymal Stem Cells in Female Infertility Treatment: Protocols and Preliminary Results.

Chatzianagnosti S, Dermitzakis I, Theotokis P, Kousta E, Mastorakos G, Manthou M Life (Basel). 2024; 14(9).

PMID: 39337944 PMC: 11433628. DOI: 10.3390/life14091161.


Mining human clinical waste as a rich source of stem cells for neural regeneration.

Eivazi Zadeh Z, Nour S, Kianersi S, Jonidi Shariatzadeh F, Williams R, Nisbet D iScience. 2024; 27(8):110307.

PMID: 39156636 PMC: 11326931. DOI: 10.1016/j.isci.2024.110307.


Functional variation among mesenchymal stem cells derived from different tissue sources.

Yi N, Zeng Q, Zheng C, Li S, Lv B, Wang C PeerJ. 2024; 12:e17616.

PMID: 38952966 PMC: 11216188. DOI: 10.7717/peerj.17616.


The effect of adipose-derived mesenchymal stem cell transplantation on ovarian mitochondrial dysfunction in letrozole-induced polycystic ovary syndrome in rats: the role of PI3K-AKT signaling pathway.

Abdi A, Ranjbaran M, Amidi F, Akhondzadeh F, Seifi B J Ovarian Res. 2024; 17(1):91.

PMID: 38678269 PMC: 11056058. DOI: 10.1186/s13048-024-01422-3.


References
1.
Zhao S, Qi W, Zheng J, Tian Y, Qi X, Kong D . Exosomes Derived from Adipose Mesenchymal Stem Cells Restore Functional Endometrium in a Rat Model of Intrauterine Adhesions. Reprod Sci. 2020; 27(6):1266-1275. DOI: 10.1007/s43032-019-00112-6. View

2.
Zhu H, Jiang Y, Pan Y, Shi L, Zhang S . Human menstrual blood-derived stem cells promote the repair of impaired endometrial stromal cells by activating the p38 MAPK and AKT signaling pathways. Reprod Biol. 2018; 18(3):274-281. DOI: 10.1016/j.repbio.2018.06.003. View

3.
Li B, Zhang Q, Sun J, Lai D . Human amniotic epithelial cells improve fertility in an intrauterine adhesion mouse model. Stem Cell Res Ther. 2019; 10(1):257. PMC: 6694540. DOI: 10.1186/s13287-019-1368-9. View

4.
Zegers-Hochschild F, Adamson G, de Mouzon J, Ishihara O, Mansour R, Nygren K . International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril. 2009; 92(5):1520-4. DOI: 10.1016/j.fertnstert.2009.09.009. View

5.
Manaph N, Sivanathan K, Nitschke J, Zhou X, Coates P, Drogemuller C . An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy. Stem Cell Res Ther. 2019; 10(1):293. PMC: 6757413. DOI: 10.1186/s13287-019-1396-5. View